Recent Quotes

No recent quotes available.

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

Zacks #1 Stocks on the Move 04/21/2014

Company Name Symbol %Change
AASTROM BIOS ASTM
33.52%
ANI PHARMACE ANIP
15.26%
ADVANCED MIC AMD
12.06%
BIOLIFE SOLU BLFS
5.68%
CRAWFORD & C CRD.B
4.19%

View the PFP Archive

ZACKS
Yes or No?

This afternoon offers up the Fed's December meeting announcement and whether they are ready to start the taper. I would say the odds are close to 50/50.

My preference is for it to start now (actually my preference would have been in September when most signs pointed to this conclusion). I believe that it would send a strong signal to investors that even the cautious Fed is feeling confident in the US economy.

Sure there could be a short term dip from hyperactive traders throwing their typical hissy fits. But as the smoke clears more level headed investors will see that the pros outweigh the cons and will be glad to bid up stocks to new highs.

Featured Commentaries:

•  Explosive Stocks Under $10

•  Oil & Gas Stock Roundup

•  Can India ETFs Rebound in 2014?

•  Zacks Video: This Week's Value Stock Picks

Best,

Steve Reitmeister (aka Reity...pronounced "Righty")

Executive Vice President

Zacks Investment Research

Follow Us:  

Please login to Zacks.com or register to post a comment.

Sponsor

This Is Your Perfect Chance to See ALL Zacks' Picks

Given today's market, right now is the best time to claim full access to all of our private buy and sell recommendations. You'll even see the stocks that are so exclusive they've been closed to the public. What a perfect way to bolster your portfolio with the best short-term trades and long-term investments no matter what the market is doing.

Today, you can get thousands of dollars worth of services at a low price for 30 days. Plus, the picks are backed by the boldest guarantee we ever made.

See our latest stocks today >>

Bull & Bear of the Day

Zacks Rank #1

Towers Watson (TW)

Looking for a way to play the growth of health care exchanges?

 

Zacks Rank #5

Big Lots (BIG)

This discount retailer is selling its Canadian operations in an attempt to turn things around.


Stock Picking Strategies

Chemical Industry Stock Outlook - Dec 2013  ››

Avoiding the 3 Pitfalls of 'Buy & Hold' Investing  ››

Roundtable Top Picks for the Week of Dec. 16th  ››


Funds Commentary

Zacks #1 Ranked BlackRock Funds  ››

Santa Claus Rally: 3 ETFs on the Nice List  ››

3 Income ETFs to Watch Ahead of Key Fed Meeting  ››


Options Strategies

Two Bullish Strategies to Make Money With Options  ››


Video Reports

Taking a Look Back

Find out what our strategists feel were top stories for 2013.

This Week's Value Stock Picks: (HNR) (KKR)- Dec 17, 2013

Value stock strategist, Tracey Ryniec, discusses Harvest Natural Resources (HNR) and KKR (KKR).

Global Stock Market Outlook for 2014

What Kind of Year is in Store for the non-U.S. World?

Earnings HQ

Today's Noteworthy Earnings Before the Bell:   ››  FDXGISLENVCINX

Today's Noteworthy Earnings After the Bell:   ››  ORCLPAYXSCSMLHRAPOG

Get the First Calendar Made for Traders.

Visit the Zacks Earnings Calendar

Recent Earnings Winners

Company Symbol Reported Surprise %Price Chg
HICKOK INC CL A HICKA Dec 16 +0.01% +7.55%
JABIL CIRCUIT INC JBL Dec 17 +0.63% +0.20%
VERIFONE SYSTEMS INC PAY Dec 17 +0.13% +0.08%
HEICO CORP HEI Dec 17 +0.44% +0.02%

See All »

Best Earnings ESP Stocks  

Company Symbol Consensus
Est.
Most
Accurate Est.
Reports Zacks Rank ESP
WINNEBAGO WGO 0.39 0.43 Dec 19 1 +10.26
APOGEE ENTRPRS APOG 0.33 0.34 Dec 18 2 +3.03
WORTHINGTON IND WOR 0.56 0.58 Dec 19 2 +3.57
FEDEX CORP FDX 1.65 1.70 Dec 18 2 +3.03
WESTON GEORG-TS T.WN 1.43 1.45 Dec 17 2 +1.40
Don't trade these stocks until you have read the Zacks ESP Guide

Sponsor

Beat the Market with Zacks' Top 10 Stocks for 2014

This long-term investing opportunity perfectly positions you for market-beating gains no matter the direction the market heads. In 2013, we had a phenomenal +40.1% return through the end of November, handily beating the S&P 500 index. And in 2012, it returned +31.7%, nearly triple the +12.1% S&P 500 return. Don't miss the continued success we anticipate sharing in 2014.

Be among the first to get in on these 10 ripe profit opportunities before they're released.

Get details now >>


Manage Your Newsletter Subscriptions

Update Preferences         Update Your Profile         Unsubscribe All         Feedback         Send to a Friend
 

This free resource is being sent by Zacks.com to our subscribers. We look for investment resources and inform you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable.

All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, brokerage, market making or asset management activities of any securities. Visit www.zacks.com/performance for information about the performance numbers displayed in this press release.

Zacks Emails

If you would prefer to not receive future profit-producing emails from Zacks.com the primary purpose of which is the commercial advertisement or promotion of a commercial product or service, then please click here and confirm your request. If you have trouble with the unsubscribe link, please email support@zacks.com.

Zacks Investment Research, Inc.
111 N. Canal St., Suite 1101
Chicago, Illinois 60606

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.